Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
批准号:
9909360
负责人:
Tuan Le Mau
金额:
$44.97万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-01 至 2020-12-31
关键词:
AdhesivesAgeAge-YearsAgingAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmplifiersAnesthesia proceduresAnestheticsBlood PressureBrainCaringCognitionCognitiveComputer softwareDataDeliriumDementiaElectrodesElectroencephalographyElectromagneticsGeneral AnesthesiaHealthHeart RateHourHumanImpaired cognitionIncidenceIndividualLifeMeasurementModernizationMonitorNeurosciencesNoiseOperative Surgical ProceduresPatientsPerformancePhasePhysiologicalPhysiologyResolutionRespirationRiskSafetyScienceSedation procedureSystemTechnologyTestingTimeUnconscious StateUnited StatesWireless TechnologyWorkage relatedbasebiomaterial compatibilitycytotoxicitydesignelectric impedanceexperiencehigh riskimprovedindividual patientinsightirritationmiddle agemild cognitive impairmentmortalitynovelolder patientpost-operative cognitive dysfunctionpostoperative deliriumproduct developmentprototyperesponsesedativesensorsexsignal processingtouchscreenwearable device
中文摘要
项目总结
在美国,每天有近10万名患者接受全身麻醉和镇静,以安全地接受
外科手术和非外科手术。这些患者中有很高比例的人年龄超过65岁。这些
年龄较大的患者术后精神错乱和认知功能障碍的风险更高。这些老年患者中的许多人
患有痴呆症,包括轻度认知障碍或阿尔茨海默病,进一步增加了他们患POD的风险
和POCD。麻醉师熟悉如何调整麻醉管理以适应
老年患者的全身生理学,例如血压、心率或呼吸。不幸的是,在现有的
技术,麻醉师没有生理原则性的方法来解释年龄相关的变化
大脑对麻醉药的反应。今天的麻醉性脑监测器是在20世纪90年代发展起来的S
并且没有解释最近描述的麻醉期间大脑活动随年龄的变化。什么时候
现在使用这些过时的监护仪,年龄较大的患者接受更多麻醉的可能性高达10倍
而不是维持无意识所必需的。简而言之,目前可用的麻醉性脑监测器是基于
过时的科学和技术,使老年患者容易受到不必要的高麻醉剂暴露。
对老年患者以及痴呆症和/或阿尔茨海默病患者的影响可能是显著的,
由于麻醉剂暴露的增加与精神错乱的发生率增加有关,因此术后认知
功能障碍,甚至死亡。Pascall Systems,Inc.建议开发新的系统和个性化
在全身麻醉和镇静期间监测衰老、痴呆症和阿尔茨海默病患者的算法。
英文摘要
PROJECT SUMMARY
In the United States, nearly 100,000 patients receive general anesthesia and sedation daily to safely undergo
surgical and non-surgical procedures. A high proportion of these patients are older than 65 years of age. These
older patients are at higher risk of post-operative delirium and cognitive dysfunction. Many of these older patients
have dementia, including mild cognitive impairment or Alzheimer’s disease, further elevating their risk of POD
and POCD. Anesthesiologists are familiar with how to adjust anesthetic management to account for changes in
systemic physiology in older patients, e.g., blood pressure, heart rate, or respiration. Unfortunately, with existing
technologies, anesthesiologists have no physiologically principled way to account for age-dependent changes
in the brain’s response to anesthetic drugs. Today’s anesthetic brain monitors were developed in the 1990’s
and do not account for recently-described age-dependent changes in brain activity during anesthesia. When
these now outdated monitors are used, older patients are up to 10-times more likely to receive more anesthesia
than necessary to maintain unconscious. In short, currently available anesthetic brain monitors are based on
outdated science and technology and predispose older patients to unnecessarily high anesthetic exposures.
The consequences for older patients and patients with dementia and/or Alzheimer’s disease can be significant,
since increased anesthetic exposure is associated with increased incidence of delirium, post-operative cognitive
dysfunction, and even mortality. PASCALL Systems, Inc. proposes to develop novel systems and personalized
algorithms to monitor aging, dementia, and Alzheimer’s disease patients during general anesthesia and sedation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care
-
批准号:10604993
-
项目类别:
-
资助金额:$47.44万
-
财政年份:2023
-
负责人:Tuan Le Mau
-
依托单位:
Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients
-
批准号:10760816
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2023
-
负责人:Tuan Le Mau
-
依托单位:
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
-
批准号:10360566
-
项目类别:
-
资助金额:$121.49万
-
财政年份:2021
-
负责人:Tuan Le Mau
-
依托单位:
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients
-
批准号:10303200
-
项目类别:
-
资助金额:$122.77万
-
财政年份:2021
-
负责人:Tuan Le Mau
-
依托单位:
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements
-
批准号:10595838
-
项目类别:
-
资助金额:$99.48万
-
财政年份:2020
-
负责人:Tuan Le Mau
-
依托单位:
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements
-
批准号:10157621
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2020
-
负责人:Tuan Le Mau
-
依托单位:
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements
-
批准号:10654060
-
项目类别:
-
资助金额:$98.18万
-
财政年份:2020
-
负责人:Tuan Le Mau
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: